95 related articles for article (PubMed ID: 23071008)
1. Application of a substrate cocktail approach in the assessment of cytochrome P450 induction using cultured human hepatocytes.
Pelletier RD; Lai WG; Wong YN
J Biomol Screen; 2013 Feb; 18(2):199-210. PubMed ID: 23071008
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy.
Gerin B; Dell'Aiera S; Richert L; Smith S; Chanteux H
Xenobiotica; 2013 Apr; 43(4):320-35. PubMed ID: 23153057
[TBL] [Abstract][Full Text] [Related]
3. Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.
Graham RA; Tyler LO; Krol WL; Silver IS; Webster LO; Clark P; Chen L; Banks T; LeCluyse EL
J Biochem Mol Toxicol; 2006; 20(2):69-78. PubMed ID: 16615094
[TBL] [Abstract][Full Text] [Related]
4. A 96-well plate assay for CYP4503A induction using cryopreserved human hepatocytes.
Kamiguchi N; Aoyama E; Okuda T; Moriwaki T
Drug Metab Dispos; 2010 Nov; 38(11):1912-6. PubMed ID: 20699409
[TBL] [Abstract][Full Text] [Related]
5. The use of a substrate cassette strategy to improve the capacity and throughput of cytochrome P450 induction studies in human hepatocytes.
Mohutsky MA; Petullo DM; Wrighton SA
Drug Metab Dispos; 2005 Jul; 33(7):920-3. PubMed ID: 15802386
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
[TBL] [Abstract][Full Text] [Related]
7. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
[TBL] [Abstract][Full Text] [Related]
8. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
[TBL] [Abstract][Full Text] [Related]
9. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
10. In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
Dickmann LJ; VandenBrink BM; Lin YS
Drug Metab Dispos; 2012 Jul; 40(7):1263-7. PubMed ID: 22531045
[TBL] [Abstract][Full Text] [Related]
11. Induction of the metabolism of midazolam by rifampin in cultured porcine hepatocytes: preliminary evidence for CYP3A isoforms in pigs.
Hosagrahara VP; Hansen LK; Remmel RP
Drug Metab Dispos; 1999 Dec; 27(12):1512-8. PubMed ID: 10570035
[TBL] [Abstract][Full Text] [Related]
12. Cytochromes P450 (CYP) in the Poeciliopsis lucida hepatocellular carcinoma cell line (PLHC-1): dose- and time-dependent glucocorticoid potentiation of CYP1A induction without induction of CYP3A.
Celander M; Hahn ME; Stegeman JJ
Arch Biochem Biophys; 1996 May; 329(1):113-22. PubMed ID: 8619627
[TBL] [Abstract][Full Text] [Related]
13. Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions.
Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
Drug Metab Dispos; 2012 Apr; 40(4):706-16. PubMed ID: 22228749
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P450 enzymes in primary equine hepatocyte culture.
Stefanski A; Mevissen M; Möller AM; Kuehni-Boghenbor K; Schmitz A
Toxicol In Vitro; 2013 Oct; 27(7):2023-30. PubMed ID: 23916975
[TBL] [Abstract][Full Text] [Related]
15. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
16. Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development.
Mori K; Hashimoto H; Takatsu H; Tsuda-Tsukimoto M; Kume T
Xenobiotica; 2009 Jun; 39(6):415-22. PubMed ID: 19480547
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry.
Lahoz A; Donato MT; Picazo L; Castell JV; Gómez-Lechón MJ
Drug Metab Lett; 2008 Aug; 2(3):205-9. PubMed ID: 19356095
[TBL] [Abstract][Full Text] [Related]
18. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the establishment of a fish CYP3A induction model.
Li D; Yang XL; Zhang SJ; Lin M; Yu WJ; Hu K
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jan; 147(1):17-29. PubMed ID: 17826359
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cytochrome P450 activities in human hepatocytes in vitro.
Gómez-Lechón MJ; Lahoz A; Castell JV; Donato MT
Methods Mol Biol; 2012; 806():87-97. PubMed ID: 22057447
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytochrome P450: assessment in an immortalized human hepatocyte cell line (Fa2N4) using a novel higher throughput cocktail assay.
Youdim KA; Tyman CA; Jones BC; Hyland R
Drug Metab Dispos; 2007 Feb; 35(2):275-82. PubMed ID: 17108058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]